Clinical Trials Browser

Phase 1 × Carcinoma, Non-Small-Cell Lung × Radiation Dose Hypofractionation × Clear all

NCT03509584 2023-06-15

Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung